MBRX ▲ +14.5% - Moleculin Biotech, Inc.
$MBRX - Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR
25-SEP-2026 01:05 PM ET
Share this post
More filings for $MBRX
MBRX ▲ +1.8% - Moleculin Biotech, Inc.Sep 23, 2026MBRX ▲ +4.2% - Moleculin Biotech, Inc.Sep 14, 2026MBRX ▼ -2.4% - Moleculin Biotech, Inc.Sep 11, 2026MBRX - Moleculin Biotech, Inc. - SEC Filing Update (25-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 25, 2026MBRX - Moleculin Biotech, Inc. - SEC Filing Update (25-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 25, 2026MBRX - Moleculin Biotech, Inc. - SEC Filing Update (10-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 10, 2026
View full $MBRX filing history →💬 Comments
Loading comments…
Leave a comment